The 12th annual Spirit of the Heart Virtual Awards Gala & Fundraiser, to be conducted as a virtual event on Saturday, October 16th, from 7:00 PM to 9:00 PM EST, provides an opportunity for individuals to support the efforts of the ABC to remove barriers to optimal heart health in minority populations.
Personalized antiplatelet therapy using platelet function testing can decrease ischemic events in stable CAD.
This study evaluated the effects of hemodynamic-guided management of heart failure on composite mortality and heart failure events.
Researchers evaluated inpatient discharge data from the AHRQ Healthcare Cost and Utilization Project Nationwide Inpatient Sample to assess outcomes associated with acute idiopathic pericarditis.
The anti-inflammatory benefits of colchicine were consistently observed in this study, regardless of specific history and timing of prior ACS.
Authors performed a systematic review of current evidence for the use of the Atrial Fibrillation Better Care (ABC) pathway and its effect on clinical outcomes.
The study authors conducted a systematic review and meta-analysis to assess the overall efficacy and safety of low-dose direct oral anticoagulants vs placebo on a background of antiplatelet therapy.
Investigators report findings from the ACTION trial assessing outcomes of therapeutic vs prophylactic oral anticoagulant use among hospitalized adult patients with COVID-19 and elevated D-dimer concentration.
Atrial Fibrillation risk was examined for patients with cancer from 2009 through 2017.